Cystic Fibrosis Trial, Recruiting (NCT04026360)

Cystic Fibrosis Trial, Recruiting NCT04026360 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT04026360 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient must be an infant or child who has been diagnosed with cystic fibrosis (CF) through newborn screening
The patient must be 18 years old or younger
Written permission (consent) must be provided by the patient and/or their parent or guardian

Who may not be able to join:

The patient has needed breathing support (such as a ventilator or oxygen assistance) for more than three days
The patient has serious birth defects or other significant health conditions beyond cystic fibrosis
The patient's mother has a history of drug abuse
The patient's mother has a known serious medical condition
There are significant difficulties communicating with the patient or their family (confirm with trial site)
The patient has a pacemaker or wears a continuous glucose monitor (a device that tracks blood sugar levels)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philipp Latzin, MD PhD, University Children's Hospital Bern

Phone: 0041 31 632 94 93

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04026360

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: 0041 31 632 94 93

More information: https://clinicaltrials.gov/study/NCT04026360

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient must be an infant or child who has been diagnosed with cystic fibrosis (CF) through newborn screening
The patient must be 18 years old or younger
Written permission (consent) must be provided by the patient and/or their parent or guardian

Who may not be able to join:

The patient has needed breathing support (such as a ventilator or oxygen assistance) for more than three days
The patient has serious birth defects or other significant health conditions beyond cystic fibrosis
The patient's mother has a history of drug abuse
The patient's mother has a known serious medical condition
There are significant difficulties communicating with the patient or their family (confirm with trial site)
The patient has a pacemaker or wears a continuous glucose monitor (a device that tracks blood sugar levels)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

1 July 2011

Est. completion

31 August 2050

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Multiple Breath Washout; Spirometry; Body plethysmography; Magnetic Resonance Imaging (MRI); Nasal swabs; Weekly swabs; Swabs during respiratory infection; Routine swabs in CF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov